[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Rühl
G H
GH
Abteilung für Orale Pathologie, St. Josef-Hospital Bochum.
Börsch
G
G
D000658:Amoxicillin / Q000008:administration & dosage*; D001729:Bismuth; D002169:Campylobacter Infections / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005753:Gastric Mucosa / Q000473:pathology*; D005756:Gastritis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008795:Metronidazole / Q000008:administration & dosage*; D009942:Organometallic Compounds / Q000008:administration & dosage*; D010437:Peptic Ulcer / Q000188:drug therapy*; D012459:Salicylates / Q000008:administration & dosage*
D009942:Organometallic Compounds; D012459:Salicylates; D008795:Metronidazole; C015715:bismuth subsalicylate; D000658:Amoxicillin; D001729:Bismuth
Morphologischer Wandel der C.p.-assoziierten Gastritis unter und nach erfolgreicher antibakterieller Therapie.